Physician profile
Noor Ahmad
NPI 1073741468
$110,552.21
in general payments reported to CMS, 2019-2025
22 companies · $26K in 2025
The $26K reported for 2025 was more than what 94% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,884 · 2020: $713 · 2021: $2,746 · 2022: $3,077 · 2023: $39K · 2024: $35K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $60K · Travel and Lodging: $26K · Food and Beverage: $15K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $59,700.00 |
| Travel and Lodging | $25,829.88 |
| Food and Beverage | $14,602.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $63,070.94 | 2019-2025 | Indigo System, Ruby Coil, Penumbra System |
| Sirtex Medical INC | $24,059.31 | 2022-2025 | Sir-Spheres Microspheres |
| Ge Healthcare | $14,124.66 | 2025 | |
| Argon Medical Devices, INC. | $2,529.08 | 2020-2025 | Cleaner, Clot Management, Clot Management |
| Trisalus Life Sciences, INC. | $1,839.82 | 2022-2025 | Trinav Infusion System |
| Boston Scientific Corporation | $1,096.48 | 2021-2024 | Therasphere Administration Set, Obsidio, Embold Fibered |
| Medtronic, INC. | $1,008.11 | 2022-2025 | Emprint, Ellipsys Vascular Access System, Osteocool Rf Ablation System |
| Balt USA, LLC | $850.32 | 2022-2025 | Prestige Coil System, Revere Hybrid Access Catheter |
| Abbott Laboratories | $483.11 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $425.39 | 2021-2025 | Denali Vena Cava Filter, Venovo, Covera |
| Inari Medical, INC. | $343.82 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Angiodynamics, INC. | $188.36 | 2019-2025 | Bioflo |
| Siemens Medical Solutions USA, INC. | $117.48 | 2022 | |
| Imperative Care, INC | $102.88 | 2025 | Symphony Catheter |
| Terumo Medical Corporation | $69.18 | 2019-2025 | Angio-Seal, Tr Band, Navicross |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $63.27 | 2021-2024 | Zilver Vena, Cook Celect |
| Becton, Dickinson and Company | $42.79 | 2023-2024 | Lutonix Drug Coated Balloon, Denali Vena Cava Filter |
| Medtronic Vascular, INC. | $37.27 | 2020 | |
| B. Braun Interventional Systems INC. | $28.37 | 2021 | |
| Microvention, INC. | $27.91 | 2025 | Sofia 6f-131cm Str, Tubing Kit - Stroke |
| Biocompatibles, INC. | $22.43 | 2019 | |
| Cardinal Health 200 LLC | $21.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noor Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.